Sight Sciences, Inc. engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases.Its products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients. The company was incorporated in 2010 and is headquartered in Menlo Park, California.